These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 2510486
1. The use of antiarrhythmic agents in heart failure: implications of CAST. Gottlieb SS. Am Heart J; 1989 Nov; 118(5 Pt 1):1074-7. PubMed ID: 2510486 [No Abstract] [Full Text] [Related]
2. Encainide and flecainide in children: separating the wheat from the chaff. Perry JC, Garson A. J Am Coll Cardiol; 1991 Aug; 18(2):366-7. PubMed ID: 1906903 [No Abstract] [Full Text] [Related]
3. An interim perspective on the removal of encainide and flecainide from the cardiac arrhythmia suppression trial. Coyle JD, Schaal SF. DICP; 1989 Jun; 23(6):478-9. PubMed ID: 2500783 [No Abstract] [Full Text] [Related]
4. Lessons from the cardiac arrhythmia suppression trial. Garratt C, Ward DE, Camm AJ. BMJ; 1989 Sep 30; 299(6703):805-6. PubMed ID: 2510839 [No Abstract] [Full Text] [Related]
5. The events surrounding the removal of encainide and flecainide from the Cardiac Arrhythmia Suppression Trial (CAST) and why CAST is continuing with moricizine. Bigger JT. J Am Coll Cardiol; 1990 Jan 30; 15(1):243-5. PubMed ID: 2104884 [No Abstract] [Full Text] [Related]
6. Drugs for cardiac arrhythmias: new warning. Med Lett Drugs Ther; 1989 May 19; 31(792):48. PubMed ID: 2497313 [No Abstract] [Full Text] [Related]
7. Lessons to be learned from the cardiac arrhythmia suppression trial. Podrid PJ, Marcus FI. Am J Cardiol; 1989 Nov 15; 64(18):1189-91. PubMed ID: 2510491 [No Abstract] [Full Text] [Related]
8. Flecainide and CAST. Lancet; 1989 Aug 26; 2(8661):481-2. PubMed ID: 2570188 [No Abstract] [Full Text] [Related]
9. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N Engl J Med; 1989 Aug 10; 321(6):406-12. PubMed ID: 2473403 [Abstract] [Full Text] [Related]
10. Implications of the Cardiac Arrhythmia Suppression Trial for antiarrhythmic drug treatment. Bigger JT. Am J Cardiol; 1990 Feb 20; 65(8):3D-10D; discussion 68D-71D. PubMed ID: 2106253 [Abstract] [Full Text] [Related]
11. CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. Akhtar M, Breithardt G, Camm AJ, Coumel P, Janse MJ, Lazzara R, Myerburg RJ, Schwartz PJ, Waldo AL, Wellens HJ. Circulation; 1990 Mar 20; 81(3):1123-7. PubMed ID: 1689621 [No Abstract] [Full Text] [Related]
12. Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS. Cardiac Arrhythmia Pilot Study (CAPS) InvestigatorsThe CAPS Coordinating Center, University of Washington, JD-22, 1107 Northeast 45th, Room 505, Seattle, Washington 98105, USA.. Am J Cardiol; 1988 Mar 01; 61(8):501-9. PubMed ID: 2894169 [Abstract] [Full Text] [Related]
13. Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group. Fish FA, Gillette PC, Benson DW. J Am Coll Cardiol; 1991 Aug 01; 18(2):356-65. PubMed ID: 1906902 [Abstract] [Full Text] [Related]
19. Fact and fiction--results of the cardiac arrhythmia suppression trial. Wyse DG. Can J Cardiol; 1991 Aug 01; 7(1):51-4; discussion 55-8. PubMed ID: 1902755 [No Abstract] [Full Text] [Related]
20. CAST and beyond. Implications of the cardiac arrhythmia suppression trials. By the Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J; 1990 Mar 01; 11(3):194-9. PubMed ID: 2108031 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]